Literature DB >> 30277559

Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy: Progress Continues.

Barthelemy Diouf1,2, William E Evans1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30277559      PMCID： PMC6355340          DOI： 10.1002/cpt.1209

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  9 in total

1.  Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression.

Authors:  P Kuehl; J Zhang; Y Lin; J Lamba; M Assem; J Schuetz; P B Watkins; A Daly; S A Wrighton; S D Hall; P Maurel; M Relling; C Brimer; K Yasuda; R Venkataramanan; S Strom; K Thummel; M S Boguski; E Schuetz
Journal:  Nat Genet       Date:  2001-04       Impact factor: 38.330

2.  Vincristine pharmacogenomics: 'winner's curse' or a different phenotype?

Authors:  Barthelemy Diouf; Kristine R Crews; William E Evans
Journal:  Pharmacogenet Genomics       Date:  2016-02       Impact factor: 2.089

3.  Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia.

Authors:  Akinbode Egbelakin; Michael J Ferguson; Emily A MacGill; Amalia S Lehmann; Ariel R Topletz; Sara K Quinney; Lang Li; Kevin C McCammack; Stephen D Hall; Jamie L Renbarger
Journal:  Pediatr Blood Cancer       Date:  2010-11-11       Impact factor: 3.167

4.  Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.

Authors:  Chee Geap Tay; Vanessa Wan Mun Lee; Lai Choo Ong; Khean Jin Goh; Hany Ariffin; Choong Yi Fong
Journal:  Pediatr Blood Cancer       Date:  2017-01-31       Impact factor: 3.167

5.  Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.

Authors:  Barthelemy Diouf; Kristine R Crews; Glen Lew; Deqing Pei; Cheng Cheng; Ju Bao; Jie J Zheng; Wenjian Yang; Yiping Fan; Heather E Wheeler; Claudia Wing; Shannon M Delaney; Masaaki Komatsu; Steven W Paugh; Joseph Robert McCorkle; Xiaomin Lu; Naomi J Winick; William L Carroll; Mignon L Loh; Stephen P Hunger; Meenakshi Devidas; Ching-Hon Pui; M Eileen Dolan; Mary V Relling; William E Evans
Journal:  JAMA       Date:  2015-02-24       Impact factor: 56.272

6.  CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemia.

Authors:  Richard Aplenc; Wendy Glatfelter; Peggy Han; Eric Rappaport; Mei La; Avital Cnaan; M Anne Blackwood; Beverly Lange; Timothy Rebbeck
Journal:  Br J Haematol       Date:  2003-07       Impact factor: 6.998

7.  An Inherited Genetic Variant in CEP72 Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia.

Authors:  W Stock; B Diouf; K R Crews; D Pei; C Cheng; K Laumann; S J Mandrekar; S Luger; A Advani; R M Stone; R A Larson; W E Evans
Journal:  Clin Pharmacol Ther       Date:  2016-11-16       Impact factor: 6.875

8.  Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients.

Authors:  Jamie L Renbarger; Kevin C McCammack; Caroline E Rouse; Stephen D Hall
Journal:  Pediatr Blood Cancer       Date:  2008-04       Impact factor: 3.167

9.  Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes.

Authors:  Galen E B Wright; Ursula Amstutz; Britt I Drögemöller; Joanne Shih; Shahrad R Rassekh; Michael R Hayden; Bruce C Carleton; Colin J D Ross
Journal:  Clin Pharmacol Ther       Date:  2018-08-17       Impact factor: 6.875
  9 in total
  2 in total

1.  Suppression of TRPV1/TRPM8/P2Y Nociceptors by Withametelin via Downregulating MAPK Signaling in Mouse Model of Vincristine-Induced Neuropathic Pain.

Authors:  Adnan Khan; Bushra Shal; Ashraf Ullah Khan; Rahim Ullah; Muhammad Waleed Baig; Ihsan Ul Haq; Eun Kyoung Seo; Salman Khan
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

2.  Defining Clinical Utility of Germline Indicators of Toxicity Risk: A Perspective.

Authors:  Daniel L Hertz; Lisa M McShane; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2022-03-24       Impact factor: 50.717
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.